Literature DB >> 18340121

PROVE-IT TIMI 22 Study: potential effects on critical pathways for acute coronary syndrome.

Christopher P Cannon1.   

Abstract

Entities:  

Year:  2003        PMID： 18340121     DOI： 10.1097/01.hpc.0000086202.17560.4b

Source DB:  PubMed          Journal:  Crit Pathw Cardiol        ISSN： 1535-2811


× No keyword cloud information.
  1 in total

1.  Effects of fenofibrate treatment on cardiovascular disease risk in 9,795 individuals with type 2 diabetes and various components of the metabolic syndrome: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.

Authors:  Russell Scott; Richard O'Brien; Greg Fulcher; Chris Pardy; Michael D'Emden; Dana Tse; Marja-Riitta Taskinen; Christian Ehnholm; Anthony Keech
Journal:  Diabetes Care       Date:  2008-11-04       Impact factor: 19.112
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.